← Leaderboards
Samantha Dunmire
Luminary Therapeutics, Inc.
$397,422
Attributed
$397,422
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$397,422 · 1
By mechanism
R43$397,422 · 1
Top collaborators
No co-investigators on record.
Most similar at Luminary Therapeutics, Inc.
Same institution · by research overlap
- Nicole J. Shirkey-Son$1,017,866
- Samuel Hickenlooper$399,256
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAffinityAnimal ModelAntigen ReceptorsAntigensAntigen-Specific T CellsAntitumor ResponseAutologousBaseBiotechnologyCancer PrognosisCancer TherapyCd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesCd8 ReceptorCell KillingCell LineCell ModelCell PhysiologyCellsCell TherapyChimeric Antigen ReceptorAdvanced Pancreatic Cancer